Refine by
Vaccine Based Articles & Analysis
36 articles found
In the field of vaccine development, peptide vaccines, as an emerging vaccine platform, have gradually become the focus of research due to their advantages such as high safety, strong targeting, and customizability. ...
Once synthesized, these proteins spontaneously assemble into VLPs, providing a scalable and efficient way to produce vaccines. Applications in Vaccination VLPs have shown considerable promise in the field of vaccination. Their ability to mimic the structure of real viruses enables them to effectively stimulate the immune system. ...
Encapsulating anticancer drugs within its lipid bilayer improves drug accumulation in target tissues while reducing toxicity to healthy cells.Immunomodulatory TherapyFunctionalized DSPE-PEG-Mannose nanoparticles can modulate immune responses by interacting with mannose receptors on immune cells, contributing to novel treatments for immune-related disorders.Cell Recognition and SeparationBy ...
Lessons learned from COVID-19 treatments are being applied to other viral diseases, helping to develop more effective immune-based therapies. Vaccine Innovations Vaccine development has taken center stage in the fight against viral infections. ...
Notable examples include peptide hormones like insulin and drugs used in cancer treatment. Vaccines Synthetic peptides are employed in the development of vaccines, providing a safe and stable alternative to traditional attenuated or inactivated pathogens. Peptide-based vaccines are designed to elicit specific immune responses, ...
·Cell-Based Vaccines: Tumor cells or immune cells are modified to present the target antigens and stimulate an immune response. Applications and Functions of Cancer Vaccines Cancer vaccines serve several purposes in oncology. For illustration, the HPV vaccine helps prevent cervical cancer by targeting ...
Alfa Cytology has announced pancreatic cancer vaccine development services to improve the efficacy and safety of related vaccines. ...
The stability in vivo and effective protein synthesis in vitro are essential for ensuring the efficacy of mRNA-based vaccines and therapies. In vitro transcribed (IVT) mRNA needs to be capped at the 5' end through post-transcriptional enzyme capping or co-transcriptional capping. The 5' cap is a critical quality attribute (CQA) of IVT mRNA, which needs to be ...
Introduction RNA Lipid Nanoparticles (LNP) technology has rapidly gained prominence in the health and scientific domain, primarily due to its significant role in carrying the mRNA of the COVID-19 vaccines developed by Pfizer/BioNTech and Moderna. Yet, the potential of this technology spans beyond the confines of these vaccines or even the health industry. ...
This information can be used to develop glycan-based vaccines, diagnostics, and therapeutics. Glycan-Virus Interactions: Glycan arrays have been used to study the interactions between glycans and viruses. ...
At present, the most effective vaccine is the mRNA vaccine developed by Pfizer-BioNTech and Moderna. ...
For example, the 36-amino acid peptide enfuvirtide (brand name Fuzeon®) inhibits the fusion of the gp41 HIV viral envelope protein with cell membranes, preventing viral entry into cells. From a vaccine perspective, the V3 loop of the gp120 envelope protein of HIV-1 (HIV envelope variable region 3, V3) has been identified as a candidate for peptide-based ...
Besides, such bespoke services also facilitate site-specific modifications that help deal with immune responses or reflect a particular codon bias: a feature that substantially amplifies the practical applications of this technology in therapeutics, vaccination, and research. The synthesis process in these services pays high regard to fidelity and purification. ...
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. ...
Vaccine excipients play a crucial role in the development and manufacturing of vaccines. ...
To fight these deadly infections, a pneumococcal vaccine is given to stimulate the production of antibodies against CPS. ...
In addition, viral vectors based on Newcastle disease virus have been previously evaluated as vaccines against e.g. ...
ByNuvonis
Vaccine Freezers are required for the safe storage of vaccines that must be kept at extremely low temperatures. ...
Revised estimates of disability adjusted life years (DALYs) and recent calculations based on health-related quality of life (HrQoL) points to a much higher disease burden of schistosomiasis than has previously been recognized. ...
Abera’s vaccine delivery platform works as a plug-and-play system where known or novel antigens can be engineered onto our delivery platform to create effective, multivalent vaccines that are cost-effective and fast to produce. We actively work together with academia and industry to enable the use of our vaccine delivery platform in design and development of new vaccines. Many of these ...